Earnings Ahead

EXEL - Exelixis, Inc.

19.37 0.17 0.89

Exelixis, Inc.

Exelixis, Inc.

About

Profile

Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following earl


Headquarters

Alameda, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

EXEL



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Exelixis Non-GAAP EPS of $0.10 misses by $0.09, revenue of $471.92M misses by $1.47M
  • Exelixis Q3 2023 Earnings Preview
  • Exelixis gains as Cabometyx patent trial ends (update)
  • Exelixis slumps amid Cabometyx patent trial (update)
  • Exelixis reports positive results for Cabometyx in treating neuroendocrine tumors
  • Exelixis started at buy at Wainwright on targeted oncology pipeline
  • Exelixis inks licensing deal with Insilico for tumor candidate
  • Exelixis reports positive results for Cabometyx in pancreatic cancer type
  • Exelixis appoints Amy Peterson as Chief Medical Officer
  • Exelixis lead product hits main goal in Phase 3 prostate cancer trial
  • Exelixis Non-GAAP EPS of $0.31 beats by $0.09, revenue of $469.85M beats by $25.02M
  • Exelixis Q2 2023 Earnings Preview
  • Exelixis, Teva settle patent dispute over cancer drug Cabometyx
  • Exelixis sees three Farallon nominees elected to board
  • Exelixis a new overweight at Piper Sandler on Cabometyx, pipeline
  • Exelixis Non-GAAP EPS of $0.16 misses by $0.06, revenue of $408.8M misses by $13.86M
  • Exelixis Q1 2023 Earnings Preview
  • Exelixis board member resigns; Farallon gets third board seat in victory
  • Exelixis holder Farallon files definitive materials in proxy battle
  • Exelixis supports two of Farallon's board nominees as it faces proxy fight
Date Price Open High Low Vol Change
Apr 18 22.49 23
23.23
22.46
2.6M -1.66%
Apr 17 22.87 22.9
23.29
22.82
2.8M 0.22%
Apr 16 22.82 22.6
23.08
22.53
1.7M 0.53%
Apr 15 22.7 22.93
23.07
22.64
1.8M -0.48%
Apr 12 22.81 22.7
23.05
22.63
1.9M 0.71%
 
Apr 11 22.65 23.37
23.39
22.42
2.4M -4.35%
Apr 10 23.68 23.57
23.8
23.38
1.5M -0.17%
Apr 9 23.72 23.33
23.75
23.28
1.3M 1.58%
Apr 8 23.35 23.02
23.42
22.85
1.7M 0.91%
Apr 5 23.14 23.42
23.45
23.08
1.9M -1.49%
Apr 4 23.49 23.85
23.95
23.38
2.2M -0.84%
Apr 3 23.69 23.34
23.83
23.34
1.8M 1.50%
Apr 2 23.34 23.53
23.59
23.24
2.3M -1.44%
Apr 1 23.68 23.57
23.7
23.22
2.0M -0.21%
Mar 28 23.73 23.93
23.98
23.7
3.0M -0.54%
Mar 27 23.86 23.78
23.9
23.66
1.6M 1.06%
Mar 26 23.61 23.7
23.8
23.58
1.9M -0.38%
Mar 25 23.7 23.75
23.93
23.65
2.3M -0.34%
Mar 22 23.78 24.02
24.05
23.77
1.9M -0.59%
Mar 21 23.92 23.82
24.07
23.56
2.7M 0.89%
Mar 20 23.71 23.41
23.73
23.28
2.2M 1.02%
Mar 19 23.47 23.19
23.51
23.18
2.4M 1.29%
Mar 18 23.17 23.14
23.42
23.06
2.4M 0.83%
Mar 15 22.98 22.62
23.02
22.55
4.9M 1.64%
Mar 14 22.61 23.02
23.1
22.4
2.5M -1.99%
Mar 13 23.07 22.77
23.19
22.77
2.6M 1.67%
Mar 12 22.69 22.42
22.7
22.32
2.0M 1.02%
Mar 11 22.46 22.33
22.59
22.24
2.2M 1.13%
Mar 8 22.21 22.12
22.38
22.05
1.3M 0.54%
Mar 7 22.09 22.49
22.51
22.08
1.9M -1.3%
Mar 6 22.38 22.33
22.54
22.31
1.9M 0.54%
Mar 5 22.26 22.57
22.81
22.24
2.5M -1.29%
Mar 4 22.55 22.48
22.66
22.23
2.3M 1.39%
Mar 1 22.24 22.01
22.63
22.01
3.4M 1.55%
Feb 29 21.9 22.08
22.25
21.87
3.4M -0.05%
Feb 28 21.91 21.64
22.03
21.49
2.6M 0.92%
Feb 27 21.71 21.97
22.03
21.61
2.8M -1.14%
Feb 26 21.96 21.49
21.99
21.49
2.3M 2%
Feb 23 21.53 21.29
21.78
21.14
2.8M 3.96%
Feb 22 20.71 20.72
20.88
20.49
1.8M -0.05%
Feb 21 20.72 20.59
20.78
20.57
2.0M 0.44%
Feb 20 20.63 20.45
20.81
20.43
2.1M 0.73%
Feb 16 20.48 20.56
20.83
20.38
2.4M -0.53%
Feb 15 20.59 20.52
20.93
20.43
2.4M 0.98%
Feb 14 20.39 20.27
20.58
20.21
2.1M 0.79%
Feb 13 20.23 20.3
20.69
20.15
2.5M -0.78%
Feb 12 20.39 20.24
20.45
20.01
3.5M 0.84%
Feb 9 20.22 20.3
20.42
20.1
2.4M 0.25%
Feb 8 20.17 20.18
20.69
20.11
3.1M -0.05%
Feb 7 20.18 21.09
21.23
20.15
3.4M -7.56%
Feb 6 21.83 21.36
21.9
21.36
1.9M 2.01%
Feb 5 21.4 21.29
21.53
21.17
1.2M -0.42%
Feb 2 21.49 21.75
21.75
21.36
1.2M -1.2%
Feb 1 21.75 21.75
21.88
21.54
1.5M -0.05%
Jan 31 21.76 21.93
22.05
21.74
1.5M -0.59%
Jan 30 21.89 21.97
22.01
21.73
2.8M 0%
Jan 29 21.89 21.89
22.01
21.82
1.5M -1.04%
Jan 26 22.12 22.3
22.36
22.04
1.2M 0.14%
Jan 25 22.09 22.14
22.45
21.85
3.0M -0.09%
Jan 24 22.11 22.61
22.7
22.06
2.9M 0%